메뉴 건너뛰기




Volumn 21, Issue 17, 2003, Pages 3378-3379

Baseline heart rate-corrected QT and eligibility for clinical trials in oncology

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 0141576728     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2003.99.104     Document Type: Letter
Times cited : (30)

References (6)
  • 2
    • 0035678051 scopus 로고    scopus 로고
    • A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778, 123 in patients with solid malignancies
    • Britten CD, Rowinsky EK, Soignet S, et al: A phase I and pharmacological study of the farnesyl protein transferase inhibitor L-778, 123 in patients with solid malignancies. Clin Cancer Res 7: 3894-3903, 2001
    • (2001) Clin Cancer Res , vol.7 , pp. 3894-3903
    • Britten, C.D.1    Rowinsky, E.K.2    Soignet, S.3
  • 3
    • 0026068765 scopus 로고
    • Duration of the QT interval and total and cardiovascular mortality in healthy persons (the Framingham Heart Study experience)
    • Goldberg RJ, Bengtson J, Chen A, et al: Duration of the QT interval and total and cardiovascular mortality in healthy persons (the Framingham Heart Study experience). Am J Cardiol 67: 55-58, 1991
    • (1991) Am J Cardiol , vol.67 , pp. 55-58
    • Goldberg, R.J.1    Bengtson, J.2    Chen, A.3
  • 4
    • 0032170470 scopus 로고    scopus 로고
    • The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens
    • Elming H, Holm E, Jun L, et al: The prognostic value of the QT interval and QT interval dispersion in all-cause and cardiac mortality and morbidity in a population of Danish citizens. Eur Heart J 19: 1391-1400, 1998
    • (1998) Eur Heart J , vol.19 , pp. 1391-1400
    • Elming, H.1    Holm, E.2    Jun, L.3
  • 5
    • 84938392269 scopus 로고    scopus 로고
    • Trisenox New Drug Application No. 21-248, Section 6.2.4
    • Trisenox New Drug Application No. 21-248, Section 6.2.4
  • 6
    • 0027367249 scopus 로고
    • Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer
    • Schwartz CL, Hobbie WL, Truesdell S, et al: Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer. J Clin Oncol 11: 1906-1910, 1993
    • (1993) J Clin Oncol , vol.11 , pp. 1906-1910
    • Schwartz, C.L.1    Hobbie, W.L.2    Truesdell, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.